AstraZeneca, Sun Pharma Settle Over Nexium Generic
Judge Joel A. Pisano of the District of New Jersey signed off on a consent judgment preventing Sun Pharma from selling its generic Nexium IV until Jan. 1, 2014, without authorization. Other terms of the settlement were not disclosed.
“AstraZeneca has complete confidence in patents that protect Nexium IV," said Blair Hains, an AstraZeneca...
To view the full article, register now.